Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8479 | 1180 | 24.8 | 60% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1052 | 9585 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PIROXANTRONE | Author keyword | 34 | 93% | 1% | 13 |
2 | MITOXANTRONE | Author keyword | 30 | 17% | 14% | 161 |
3 | PIXANTRONE | Author keyword | 14 | 60% | 1% | 15 |
4 | BISANTRENE | Author keyword | 12 | 86% | 1% | 6 |
5 | CI 958 | Author keyword | 11 | 100% | 1% | 6 |
6 | ANTHRAPYRAZOLES | Author keyword | 9 | 83% | 0% | 5 |
7 | BBR 2778 | Author keyword | 8 | 100% | 0% | 5 |
8 | ANTHRACENEDIONE | Author keyword | 6 | 50% | 1% | 8 |
9 | KW 2170 | Author keyword | 4 | 75% | 0% | 3 |
10 | SEAP ASSAY | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PIROXANTRONE | 34 | 93% | 1% | 13 | Search PIROXANTRONE | Search PIROXANTRONE |
2 | MITOXANTRONE | 30 | 17% | 14% | 161 | Search MITOXANTRONE | Search MITOXANTRONE |
3 | PIXANTRONE | 14 | 60% | 1% | 15 | Search PIXANTRONE | Search PIXANTRONE |
4 | BISANTRENE | 12 | 86% | 1% | 6 | Search BISANTRENE | Search BISANTRENE |
5 | CI 958 | 11 | 100% | 1% | 6 | Search CI+958 | Search CI+958 |
6 | ANTHRAPYRAZOLES | 9 | 83% | 0% | 5 | Search ANTHRAPYRAZOLES | Search ANTHRAPYRAZOLES |
7 | BBR 2778 | 8 | 100% | 0% | 5 | Search BBR+2778 | Search BBR+2778 |
8 | ANTHRACENEDIONE | 6 | 50% | 1% | 8 | Search ANTHRACENEDIONE | Search ANTHRACENEDIONE |
9 | KW 2170 | 4 | 75% | 0% | 3 | Search KW+2170 | Search KW+2170 |
10 | SEAP ASSAY | 4 | 75% | 0% | 3 | Search SEAP+ASSAY | Search SEAP+ASSAY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BBR 2778 | 44 | 88% | 2% | 21 |
2 | AMETANTRONE | 42 | 75% | 3% | 30 |
3 | ANTHRAPYRAZOLES | 33 | 77% | 2% | 23 |
4 | AZA ANTHRACENEDIONE | 32 | 78% | 2% | 21 |
5 | ANTHRA1 9 CDPYRAZOL 62H ONES | 24 | 91% | 1% | 10 |
6 | UNSYMMETRICALLY SUBSTITUTED 1 4 BISAMINOALKYLAMINOANTHRACENE 9 10 DIONES | 23 | 100% | 1% | 10 |
7 | ANTHRACENEDIONE | 17 | 100% | 1% | 8 |
8 | OXANTRAZOLE | 17 | 100% | 1% | 8 |
9 | PIROXANTRONE | 17 | 100% | 1% | 8 |
10 | TRIAL COMPARING MITOXANTRONE | 16 | 54% | 2% | 20 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
MITOXANTRONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN THE CHEMOTHERAPY OF CANCER | 1991 | 220 | 310 | 57% |
The European Medicines Agency Review of Pixantrone for the Treatment of Adult Patients With Multiply Relapsed or Refractory Aggressive Non-Hodgkin's B-Cell Lymphomas: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use | 2013 | 5 | 9 | 78% |
MITOXANTRONE - A NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY | 1986 | 203 | 109 | 85% |
Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review | 2004 | 34 | 24 | 50% |
Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas | 2014 | 2 | 31 | 55% |
PHARMACOKINETICS AND METABOLISM OF MITOXANTRONE - A REVIEW | 1990 | 67 | 25 | 80% |
Separation methods for anthraquinone related anti-cancer drugs | 2001 | 29 | 67 | 51% |
Anthracene-9,10-diones and aza bioisosteres as antitumor agents | 1995 | 49 | 108 | 43% |
Mitoxantrone - A review of its pharmacological properties and use in acute nonlymphoblastic leukaemia | 1996 | 35 | 96 | 41% |
The anthrapyrazoles | 1995 | 17 | 33 | 76% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | I MURGULESCU PHYS CHEM | 1 | 33% | 0.3% | 3 |
2 | BIOL DIRECT | 1 | 50% | 0.1% | 1 |
3 | BIOMED ENGN EDUC MINIST CHONGQING CITY | 1 | 50% | 0.1% | 1 |
4 | CIENCIAS BIOL TOXICOL | 1 | 50% | 0.1% | 1 |
5 | DRUG DNA INTERACT GRP ONCOL | 1 | 50% | 0.1% | 1 |
6 | HADASSAH MED PHARMACEUT CHEM | 1 | 50% | 0.1% | 1 |
7 | UFR BIOMEDU648 | 1 | 50% | 0.1% | 1 |
8 | UNITE GRITA | 1 | 50% | 0.1% | 1 |
9 | NEUROCIENCIAS BIOL CELULAR COIMBRA | 1 | 20% | 0.3% | 3 |
10 | ADV HLTH SCI NORTH | 1 | 25% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000123665 | AN 9//SABARUBICIN//AN 7 |
2 | 0.0000089796 | NBD GLUCOSAMINE//// |
3 | 0.0000087437 | MENOGARIL//ACLARUBICIN//BIOSYNTHESIS AND PROCESSING |
4 | 0.0000086796 | SR271425//THIOXANTHONES//DIARYLSULFONES |
5 | 0.0000082170 | PYRAZOLOACRIDINE//C 1311//IMIDAZOACRIDINONES |
6 | 0.0000082098 | HIGH DOSE CHEMOTHERAPY//DOSE INTENSITY//HIGH RISK BREAST CANCER |
7 | 0.0000079235 | MODIFIED ANTIBIOT//IDARUBICINOL//IDARUBICIN |
8 | 0.0000065773 | CARDIOTOXICITY//DEXRAZOXANE//DOXORUBICIN |
9 | 0.0000061737 | PHOTOAMINATION//ANTHRAQUINONE ACID DYES//ANTHRAQUINONE ANALOGS |
10 | 0.0000059492 | METHOXYMORPHOLINO DOXORUBICIN//AD 198//METHOXYMORPHOLINYL DOXORUBICIN |